EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective

Neharika Bhadouria, Nilsson Holguin iD

JBMR Plus · 30.04.2024 · 8 (6)

DOI: 10.1093/jbmrpl/ziae048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JBMR Plus, online erschienen am 18.04.2024. Verfasst von Neharika Bhadouria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH/NIAMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low back pain derived from intervertebral disc (IVD) degeneration is a debilitating spinal condition that, despite its prevalence, does not have any intermediary guidelines for pharmacological treatment between palliative care and invasive surgery. The development of treatments for the IVD is complicated by the variety of resident cell types needed to maintain the regionally distinct structural properties of the IVD that permit the safe, complex motions of the spine. Osteoporosis of the spine increases the risk of vertebral bone fracture that can increase the incidence of back pain. Fortunately, there are a variety of pharmacological treatments for osteoporosis that target osteoblasts, osteoclasts and/or osteocytes to build bone and prevent vertebral fracture. Of particular note, clinical and preclinical studies suggest that commonly prescribed osteoporosis drugs like bisphosphonates, intermittent parathyroid hormone, anti-sclerostin antibody, selective estrogen receptor modulators and anti-receptor activator of nuclear factor-kappa B ligand inhibitor denosumab may also relieve back pain. Here, we cite clinical and preclinical studies and include unpublished data to support the argument that a subset of these therapeutics for osteoporosis may alleviate low back pain by also targeting the IVD.

Schlagwörter

Stichwörter der Autor:innen

anabolicsanimal modelsantiresorptiveshormone replacement/receptor modulatorsnucleus pulposusosteoblastsosteoclastsosteocytes

Autor:innen und Institutionen

  • Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
  • School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, United States.

ORCID-Profile: Nilsson Holguin

Förderung

  • NIAMS NIH HHS
  • NIH/NIAMS

Zitieren

APA

Bhadouria, N., & Holguin, N. (2024). Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective. JBMR Plus, 8(6). https://doi.org/10.1093/jbmrpl/ziae048

Vancouver

Bhadouria N, Holguin N. Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective. JBMR Plus. 2024;8(6). doi:10.1093/jbmrpl/ziae048

BibTeX
@article{Bhadouria2024,
  author = {Bhadouria, Neharika and Holguin, Nilsson},
  title = {Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective},
  journal = {JBMR Plus},
  year = {2024},
  volume = {8},
  number = {6},
  doi = {10.1093/jbmrpl/ziae048}
}
Kostenlos starten →